Molly Henderson
Director of Finance/CFO at PHATHOM PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-03-30
Molly Henderson active positions
Companies | Position | Start | End |
---|---|---|---|
PHATHOM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2022-04-04 | - |
Director of Finance/CFO | 2022-04-04 | - |
Career history of Molly Henderson
Former positions of Molly Henderson
Companies | Position | Start | End |
---|---|---|---|
CALLIDITAS THERAPEUTICS AB | Director/Board Member | 2020-06-24 | 2023-05-29 |
Independent Dir/Board Member | - | 2023-05-29 | |
UROGEN PHARMA LTD. | Comptroller/Controller/Auditor | 2020-09-30 | 2022-03-24 |
Director of Finance/CFO | 2020-09-30 | 2022-03-24 | |
AYALA PHARMACEUTICALS, INC. | Director of Finance/CFO | 2018-06-05 | 2020-09-24 |
IOVANCE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 2015-06-07 | 2016-07-31 |
Investor Relations Contact | 2015-06-07 | 2016-07-31 | |
VIRTUALSCOPICS INC | Director of Finance/CFO | 2003-04-30 | 2013-08-30 |
Corporate Secretary | 2009-11-01 | 2013-08-30 | |
ULTRALIFE CORPORATION | Comptroller/Controller/Auditor | 2000-07-31 | 2002-07-31 |
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Comptroller/Controller/Auditor | - | - |
Training of Molly Henderson
State University of New York at Buffalo | Graduate Degree |
Statistics
International
United States | 8 |
New Zealand | 2 |
Sweden | 2 |
Operational
Director of Finance/CFO | 5 |
Comptroller/Controller/Auditor | 4 |
Corporate Secretary | 1 |
Sectoral
Health Technology | 6 |
Commercial Services | 3 |
Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
ULTRALIFE CORPORATION | Producer Manufacturing |
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
CALLIDITAS THERAPEUTICS AB | Health Technology |
UROGEN PHARMA LTD. | Health Technology |
PHATHOM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
VirtualScopics, Inc.
VirtualScopics, Inc. Miscellaneous Commercial ServicesCommercial Services VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY. | Commercial Services |
Advaxis, Inc.
Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Molly Henderson
- Experience